Aptima HBV Quant Assay

Hepatitis Viral B Dna Detection

FDA Premarket Approval P170025 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the use of the aptima hbv quant assay on the panther system with the attachment of the panther fusion module. The changes being approved include the addition of new hardware and updated software.

DeviceAptima HBV Quant Assay
Classification NameHepatitis Viral B Dna Detection
Generic NameHepatitis Viral B Dna Detection
ApplicantHologic, Inc
Date Received2018-02-21
Decision Date2018-10-02
PMAP170025
SupplementS001
Product CodeMKT
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address Hologic, Inc 10210 Genetic Center Drive san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P170025Original Filing
S018 2022-06-16 30-day Notice
S017 2021-12-14 Real-time Process
S016 2020-07-09 30-day Notice
S015 2020-02-12 30-day Notice
S014 2019-12-23 Real-time Process
S013 2019-06-21 Normal 180 Day Track
S012 2019-04-19 30-day Notice
S011 2019-03-27 30-day Notice
S010 2019-03-18 Real-time Process
S009 2019-02-21 30-day Notice
S008 2019-01-31 30-day Notice
S007 2018-12-31 Real-time Process
S006 2018-11-29 30-day Notice
S005 2018-10-03 30-day Notice
S004 2018-05-11 135 Review Track For 30-day Notice
S003 2018-04-20 30-day Notice
S002 2018-03-12 30-day Notice
S001 2018-02-21 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.